Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Bayer
Provides health care, nutrition and high-tech material services

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.

It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro.

The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents.

The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories.

The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control.

The Animal Health segment offers prescription and nonprescription veterinary products.

The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Number of employees : 115 200 persons.
Sales per Businesses
20152016Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals13,74529.7%16,42035.1% +19.46%
Covestro11,98225.9%11,82625.3% -1.3%
Crop Science10,36722.4%9,91521.2% -4.36%
Consumer Health9,12919.7%6,03712.9% -33.87%
All Other Segments1,0972.4%1,0422.2% -5.01%
Corporate Center and Consolidation4.000%6.000% +50%
Animal Health--1,5233.3%-
Sales per Regions
20152016Delta
EUR (in Million)%EUR (in Million)%
Europe17,70438.2%---
North America12,45026.9%12,37526.5% -0.6%
Asia/Pacific10,02321.6%10,78623.1% +7.61%
Latin America/Africa/Middle East6,14713.3%---
Europe/Middle East/Africa--18,80840.2%-
Latin America--4,80010.3%-
Managers
NameAgeSinceTitle
Werner Baumann551988Chairman-Management Board
Werner Wenning711966Chairman-Supervisory Board
Johannes M. Dietsch552002Chief Financial Officer
Katharina Jansen, PhD--Head-Science & Research
Hartmut Klusik, PhD612016Head-Human Resources, Technology & Sustainability
Florian Schwalbach--Head-Information Technology & Business Services
Paul Achleitner612002Member-Supervisory Board
Reiner Hoffmann622006Member-Supervisory Board
Klaus Sturany, PhD712007Member-Supervisory Board
Oliver Zühlke492007Vice Chairman-Supervisory Board
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 826,947,808 826,947,808 100.0% 0 0.0% 100.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 20,645,612 2.50%
Norges Bank Investment Management 17,120,539 2.07%
BlackRock Fund Advisors 13,923,460 1.68%
Massachusetts Financial Services Co. 12,515,158 1.51%
BlackRock Asset Management Deutschland AG 12,217,974 1.48%
Dodge & Cox 12,095,670 1.46%
State Street Global Advisors Ltd. 10,142,735 1.23%
Lyxor International Asset Management SAS 9,552,035 1.16%
Deka Investment GmbH 8,903,273 1.08%
Fidelity Management & Research Co. 8,819,950 1.07%
Holdings
NameEquities%Valuation
Covestro (1COV) 49,810,00024.6%5,196,708,680 USD
Bayer CropScience Limited (BAYE) 24,244,68470.6%1,515,931,840 USD
Crispr Therapeutics AG (CRSP) 5,105,33012.4%96,950,217 USD
Markets and indexes
- Deutsche Boerse AG
- Prime Standard
- DAX 30 / Euro Stoxx 50, FTSE Eurotop 100, Mercado Continuo, PEA, Stoxx Europe 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  BAY:GR
- Reuters Code :  BAYG.DE
- Datastream Code :  D:BAY
Company contact information
Bayer

DE-51368 Leverkusen, Nordrhein-Westfalen
Germany

Phone : +49 214 30 1
Fax : +49
Internet : http://www.bayer.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
BAYER6.02%103 473
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386
AMGEN21.32%128 515
SANOFI-4.07%109 152
BRISTOL-MYERS SQUIBB COMPANY8.61%102 146
NOVO NORDISK A/S29.37%102 077
ABBOTT LABORATORIES42.49%96 603
ELI LILLY AND COMPANY19.50%95 289
CELGENE CORPORATION-6.52%86 140
GLAXOSMITHKLINE-17.09%84 827
ASTRAZENECA9.99%82 988
ALLERGAN PLC-19.41%57 098
SHIRE-21.33%45 962
TAKEDA PHARMACEUTICAL CO LTD28.65%43 682
CHUGAI PHARMACEUTICAL CO LTD74.07%29 167
JIANGSU HENGRUI MEDICINE CO LTD53.05%28 792
ASTELLAS PHARMA INC-11.96%26 292
Connections : Bayer
The Brookings Institution
Henkel Management AG
European Financial Services Round Table
Bayer HealthCare AG
Bayer Business Services GmbH
Currenta Geschäftsführungs GmbH
Pharmaceutical Research & Manufacturers of America
Verband der Chemischen Industrie eV
Deutscher Gewerkschaftsbund
Covestro Deutschland AG
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem